SARAH REGAN
Hematology & Oncology Physician · BALTIMORE, MD
Individual Active NPI 1487017950
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 677 | 112,136 | $8,518,435 | $2,416,777 | $1,928,815 |
| 2023 | 649 | 112,731 | $7,073,026 | $1,838,996 | $1,463,230 |
| 2022 | 75 | 838 | $95,150 | $32,084 | $25,355 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 15,550 | $3 | $2 |
| J9271 | Injection, pembrolizumab, 1 mg | 7,200 | $56 | $45 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,020 | $50 | $40 |
| J9025 | Injection, azacitidine, 1 mg | 6,300 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 4,800 | $26 | $21 |
| J0185 | Injection, aprepitant, 1 mg | 4,550 | $2 | $1 |
| J9267 | Injection, paclitaxel, 1 mg | 4,272 | $0 | $0 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,500 | $20 | $16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,336 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 680 | $1 | $1 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 644 | $4 | $3 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 530 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | D0093840 | MD |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Maryland
- NPI 1528680279
- NPI 1528572187
- NPI 1134409923
- NPI 1508085887
- NPI 1104808047
- NPI 1629411558
- NPI 1629865126
- NPI 1508908245
See all Hematology & Oncology Physician providers in Maryland →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.